[Bleomycin in the treatment of squamous cell carcinoma of the penis and bladder].
Bleomycin is an antineoplastic antibiotic with special effects on squamous cell carcinomas. Penile carcinomas in early stages may be treated with good early results by Bleomycin alone. In contrast to the normal course of penile carcinomas late recurrences and metastases may develop even after an interval of more than seven years. Therefore the monotherapy with Bleomycin is no longer recommended. The effects of Bleomycin on squamous cell carcinomas of the bladder are disappointing. The new therapeutic approach with Bleomycin and hyperthermia of the bladder may give better results.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010412:Penile Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001761:Bleomycin
Bleomycin in der Behandlung von Plattenepithelkarzinomen des Penis und der Harnblase.